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Abstract
The limited sensitivity of serological tests for mycobacterial antigens has encouraged the development of a nanoparticle probe speciﬁc for
the extrapulmonary form of Mycobacterium tuberculosis (Mtb). We developed an innovative probe comprised of super-paramagnetic iron
oxide (SPIO) nanoparticles conjugated with Mtb surface antibody (MtbsAb-nanoparticles) to provide ultrasensitive imaging of biomarkers
involved in extrapulmonary Mtb infection. MtbsAb-nanoparticles were signiﬁcantly conjugated with Mtb bacilli. The extent of contrast
enhancement reduction on magnetic resonance imaging (MRI) for Mtb and human monocytic THP1 cells was proportional to the concen-
tration of MtbsAb-nanoparticles. When MtbsAb-nanoparticles were intravenously injected into mice bearing Mtb granulomas, the granulo-
matous site showed a 14-fold greater reduction in signal intensity enhancement on T2-weighted MR images compared with an opposing
site that received PBS injection. Mtb sAb-nanoparticles represent a new non-invasive technology for the diagnosis of extrapulmonary Mtb.
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Abstract
Cholera appeared in Haiti in October 2010 for the ﬁrst time in recorded history. The causative agent was quickly identiﬁed by the Hai-
tian National Public Health Laboratory and the United States Centers for Disease Control and Prevention as Vibrio cholerae serogroup
O1, serotype Ogawa, biotype El Tor. Since then, >500 000 government-acknowledged cholera cases and >7000 deaths have occurred,
the largest cholera epidemic in the world, with the real death toll probably much higher. Questions of origin have been widely debated
with some attributing the onset of the epidemic to climatic factors and others to human transmission. None of the evidence on origin
supports climatic factors. Instead, recent epidemiological and molecular-genetic evidence point to the United Nations peacekeeping
troops from Nepal as the source of cholera to Haiti, following their troop rotation in early October 2010. Such ﬁndings have important
policy implications for shaping future international relief efforts.
Carriage of methicillin-resistant Staphylococcus aureus on admission to
European rehabilitation centres—a prospective study
E. Bilavsky1,2, Y. Lerman3, A. Rabinovich3, J. Salomon4, C. Lawrence5, A. Rossini6, A. Salvia6, J. V. Samso7, J. Fierro7,
M. Hochman1, M. Kazma1, A. Klein1, M. J. Schwaber1,2, Y. Carmeli1,2 and MOSAR WP5 study team
1) Division of Epidemiology and Preventive Medicine, 2) Sackler Faculty of Medicine, 3) Geriatric Division, Tel-Aviv Sourasky Medical Centre, Tel Aviv Univer-
sity, Tel Aviv, Israel, 4) Pharmaco Epidemiology of Infectious Diseases, Inserm U657, Institut Pasteur, CNAM (CASER, SITI, R2S2), Paris, France, 5) Depart-
ment of Microbiology, Assistance Publique Hoˆpitaux de Paris, CHU Raymond Poincare´, Hoˆpital maritime de Berck, Garches, France, 6) Fondazione Santa
Lucia IRCCS, Rome, Italy and 7) Hospital de Neurorehabilitacio´, Institut Guttmann, Barcelona, Spain
Original Submission: 21 December 2011; Revised Submission: 10 March 2012; Accepted: 14 May 2012
Editor: G. Lina
Article published online: 24 March 2012
Clin Microbiol Infect 2012; 18: E164–E169
10.1111/j.1469-0691.2012.03851.x
Abstract
This study aimed to determine the prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) carriage among
patients newly admitted to rehabilitation centres. It is a prospective study examining MRSA carriage on admission to seven rehabilitation
wards in four countries. Risk factors for MRSA carriage were analysed using univariate and multivariate analyses. A total of 1204
patients were studied. Among them, 105 (8.7%) had a positive admission MRSA screening result. The MRSA carriers were more likely
to be male, to have had a recent stay in another long-term-care facility or >2 weeks acute-care hospital stay, history of colonization
with MRSA, reduced level of consciousness, peripheral vascular disease and pressure sores. In multivariable logistic regression male gen-
der (odds ratio (OR) 2.2, 95% conﬁdence interval (CI) 1.4–3.6, p 0.001), history of MRSA positivity (OR 6.8, 95% CI 3.8–12.3,
p <0.001), peripheral vascular disease (OR 2.5, 95% CI 1.2–5, p 0.013), recent stay in another long-term-care facility (OR 2.1, 95% CI
1.3–3.5, p 0.004), or long (>2 weeks) acute-care hospital stay (OR 1.9, 95% CI 1.2–3, p 0.004), remained signiﬁcant risk factors for
MRSA carriage. MRSA carriage is common on admission to rehabilitation centres but less so, than previously described in long-term-
care facilities. Male gender, history of MRSA positivity, previous hospitalization and peripheral vascular disease may predict MRSA car-
riage, and may serve as indicators for using pre-emptive infection control measures.
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